[ad_1]
The European Medicines Agency (EMA), Turkey-based scientists Özlem and Ugur Shiner Türeci, starting with Germany-based biontech, which approves the coronavirus vaccine developed by Pfizer.
Following official authorization from the European Union (EU) Commission in line with this approval, the distribution of vaccines will begin.
Some European countries, including Germany, will begin vaccination studies from December 27.
After the UK and US approved the Pfizer – BioNTech vaccine, Germany applied to the EMA in Amsterdam, the capital of the Netherlands, to speed up the approval process for Europe.
The Scientific Committee for Human Medicines (CHMP) of the European Medicines Agency brought the meeting, which was scheduled for December 29, a week in advance.
The vaccine evaluation committee, which includes a representative from each EU member country, decided that the Pfizer – BioNTech vaccine is safe to use against coronavirus in light of the data obtained.
The committee made this decision based on thousands of pages of information provided by Pfizer, including the manufacturing process, preparation, dosage, laboratory and animal test results.
The results of the practical evaluation obtained in the UK and the US regarding the Pfizer – BioNTech vaccine also influenced the EMA’s decision.
Following the approval of the EMA, eyes now turn to the EU Commission. The Commission is expected to decide within 48 hours that the Pfizer – BioNTech vaccine will be officially licensed on the European market.
With the official authorization decision, the distribution of coronavirus vaccines produced in Germany and Belgium will begin. Starting on December 27, vaccination studies will begin in some European countries, including Germany and Belgium.
EU Commission President Ursula von der Leyen declared last week that vaccination studies in Europe will begin on December 27, 28 and 29.
Emphasizing that 10,000 health professionals are ready for vaccination at 400 different points, Germany asked the European Medicines Agency to approve coronavirus vaccines as soon as possible.
Zaventem airports in Brussels and Schipol airports in Amsterdam will be its epicenter for vaccine distribution.
The EMA will also announce its final decision on the Coronavirus vaccine developed by Moderna no later than January 12.
